FDA Import Refusal 112-6261666-2/1/1 — Caythorpe Limited
The FDA refused shipment 112-6261666-2/1/1 from Caythorpe Limited (United Kingdom) on Mar 30, 2012. The refused product falls under Devices — CHROMOGENIC IN SITU HYBRIDISATION, NUCLEIC ACID AMPLIFICATION, HER2/NEU GENE, BREAST CANCER. Cited charges: 118,237
Refusal details
- Date
- Mar 30, 2012
- Country
- United Kingdom
- Product Category
- Devices
- Product Code
- 82NYQ CHROMOGENIC IN SITU HYBRIDISATION, NUCLEIC ACID AMPLIFICATION, HER2/NEU GENE, BREAST CANCER
- Charges
- 118,237